Analytics and brochures

It is beyond doubt that merging the Russian Supreme Court and the Russian Supreme Commercial (‘Arbitration’) Court will affect the way all cases are considered, antimonopoly cases among them. This change can be attributed less to different approaches of the lawyers, i.e. the judges of one of the highest judicial institutions of the country, than to other factors which are responsible for the huge impact that the Russian Supreme Commercial (‘Arbitration’) Court has had over an extended period on how economic relations are regulated in Russia.

In December, in his annual address to the Federal Assembly, Vladimir Putin announced measures to ‘deoffshorize’ the Russian economy. It is beyond doubt that significant public resources will be allocated to ensure that the Russian President’s wishes become reality.

The Russian authorities over recent years have been actively working on reforming antimonopoly legislation. Markets undergoing vibrant growth, the gap being bridged with western regulatory rules, the role of the antimonopoly authority being bolstered – these and much more have been summoned to encourage competition in our country. However, do all initiatives of the authorities as a result justify their initial aims of developing the competitive environment?

The new regulatory system for medical devices in Russia will lead to improvements all around, but industry needs more guidance ay present. So says Vladimir Sokov, a senior partner and head of corporate division at Moscow-based legal firm Pepeliaev Group. In this interview with Ashley Yeo, he describes the new regulatory processes and explains that the market’s flatness at present is more to do with internal government issues than geopolitical unrest.

For details see